Bafna Pharmaceuticals share news and announcements
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Last close ₹442.95down ₹9.00 (1.99%)BSE ₹449.85
Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.
52-week range of traded prices to 23 Oct 2026
₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,048 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 134.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 10.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,422
Bafna Pharmaceuticals board meetings
146 filed, newest first. Page 3 of 3.
Aug 2016
Jun 2016
17 Jun · Board meeting
Board of Directors of the Company at its meeting held on June 17, 2016, considered and approved the proposal for Allotment of Equity ....
May 2016
Feb 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
30 May · Board meeting
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 29, 2015, inter alia : 1. Not recommended Dividend for the Financial ....
Mar 2015
30 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 27, 2015, has appointed Mrs. K. Sabitha as an Additional Director (Woman ....
Feb 2015
2 Feb · Board meeting
To consider the un-audited financial results for the quarter ended December 31,2014.
Oct 2014
27 Oct · Board meeting
Among others, to consider the Un-Audited Financial Results for the Quarter ending September 30, 2014.
Jul 2014
30 Jul · Board meeting
Among others, to consider the Un-Audited Financial Results for the Quarter ending 30th June, 2014.
Jun 2014
4 Jun · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has not proposed dividend for the FY ended March 31, 2014.2 Jun · Board meeting
Board of Directors of the Company at its Board Meeting held on May 30, 2014, has not proposed dividend for FY ended March 31, 2014.
May 2014
19 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2014, inter alia : 1. to consider and approve audited ....
Feb 2014
Nov 2013
8 Nov · Board meeting
Among the others to consider : (i) The Un-Audited Financial Results for the Quarter ending September 30, 2013.
Aug 2013
14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 10, 2013 has transacted the following: (1) Appointment of Mr. Kamlesh Kumar as Additional Director (Non-Executive Independent Director). And further Mr. Kamlesh Kumar was made as a member of Audit Committee. (2) Cancelled 25,00,000 convertible Warrants allotted on January 13, 2012 for nonpayment of balance money within 18 months and forfeited the 25% (application) money paid at the time of allotment of warrants. (3) Proposed the appointment of Mr. Kamlesh Kumar, Independent Director on the Board of Subsidiary M/s. Bafna Lifestyles Remedies Limited.13 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 10, 2013, inter alia, has transacted the following: 1. Appointment ....2 Aug · Board meeting
Inter alia, to consider the following: 1. The Un-Audited Financial Results for the Quarter ending June 30, 2013. 2. To consider appointment of Additional Director. 3. To consider appointment of a Director in the Board of Subsidiary M/s. Bafna Lifestyles Remedies Limited. 4. To consider cancellation of 25,00,000 warrants for non-payment of balance money within the stipulated period.
May 2013
22 May · Board meeting
Board of Directors of the Company at its meeting held on May 22, 2013, have: (1) Accepted the resignation of Mr. A. Sahasranaman, Independent Director with immediate effect, who has resigned due to personal commitments. Board placed on record their appreciation for the contribution made & valuable advices provided by him during him tenure. (2) Re-appointed Statutory Auditor subject to approval of shareholders in the forthcoming Annual General Meeting.22 May · Board meeting
Board of Directors of the Company at its meeting held on May 20, 2013, has transacted the following; 1. Accepted the resignation ....15 May · Board meeting
Inter alia;(1) To consider and approve Audited Financial Results of the Company for the year ended March 31, 2013 on Standalone and Consolidated basis.(2) To recommend payment of dividend, if any.(3) To consider re-appointment of Mr. Bafna Mahaveer Chand as Chairman and Managing Director.(4) To consider re-appointment of Mr. Paras Bafna as Whole Time Director.15 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 20, 2013, inter alia; 1. To consider and approve Audited Financial ....
Feb 2013
1 Feb · Board meeting
Among the others to consider the Un-Audited Financial Results for the quarter ending December 31, 2012
Dec 2012
27 Dec · Board meeting
Sep 2012
18 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 15, 2012, Inter alia, has approved the following: 1. Allotted ....
Aug 2012
16 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has allotted 1,25,000 Equity Shares pursuant to ....
May 2012
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, has : 1. Decided to conserve the reserves hence ....24 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 28, 2012, inter alia 1. To approve Audited Financial Results ....
Feb 2012
10 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 10, 2012, inter alia, has transacted the following: - Proposed ....
Jan 2012
13 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 13, 2012, inter alia, has approved the following; 1. Approved ....
Aug 2011
25 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 24, 2011, inter alia, has transact the following: 1. The Board ....
Jun 2011
Mar 2011
17 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 17, 2011, has allotted 15,00,000 Equity Shares of Rs. 10/- each at a premium ....
Dec 2010
6 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 06, 2010, inter alia, has transacted the business of further issue ....
May 2010
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has transacted the following: 1. Decided Not ....21 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 28, 2010, inter alia, to consider the following business: 1. ....12 May · Board meeting
Board of Directors of the Company at its meeting held on April 26, 2010, inter alia, has transacted the following: 1. Re-appointment ....